Channing Capital Management’s Labcorp LH Stock Holding History

Channing Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.4M	Buy	38,828 +1,988	+5%	+$538K	0.27%	61
2025 Q4	$9.24M	Sell	36,840 -5,626	-13%	-$1.49M	0.24%	75
2025 Q3	$12.2M	Sell	42,466 -245	-0.6%	-$65.6K	0.32%	54
2025 Q2	$11.2M	Sell	42,711 -6,425	-13%	-$1.56M	0.31%	54
2025 Q1	$11.4M	Sell	49,136 -5,603	-10%	-$1.36M	0.35%	46
2024 Q4	$12.6M	Sell	54,739 -713	-1%	-$164K	0.33%	49
2024 Q3	$12.4M	Buy	55,452 +206	+0.4%	+$45.3K	0.32%	50
2024 Q2	$11.2M	Buy	55,246 +10,515	+24%	+$2.14M	0.31%	52
2024 Q1	$9.77M	Hold	44,731	–	–	0.26%	67
2023 Q4	$10.2M	Sell	44,731 -33,723	-43%	-$7.08M	0.3%	57
2023 Q3	$15.8M	Buy	78,454 +3,955	+5%	+$834K	0.52%	44
2023 Q2	$15.4M	Sell	74,499 -11,226	-13%	-$2.18M	0.47%	48
2023 Q1	$16.9M	Sell	85,725 -26,621	-24%	-$5.48M	0.54%	46
2022 Q4	$22.7M	Buy	112,346 +82,251	+273%	+$16.1M	0.72%	45
2022 Q3	$5.29M	Buy	+30,095	New	+$6.16M	0.18%	98

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Channing Capital Management's LH Position: Q1 2026 in Review

Channing Capital Management increased its Labcorp (LH) stake by 5.4% in Q1 2026, buying an estimated $538K and bringing the position to 38,828 shares worth $10.4M. The position accounts for 0.27% of the portfolio, ranked #61.

Channing Capital Management first reported a position in LH in Q3 2022 and has held it in 15 quarters since. The position peaked at $22.7M in Q4 2022. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

Channing Capital Management held 38,828 shares of Labcorp worth $10.4M as of Q1 2026.
Channing Capital Management bought 1,988 Labcorp shares in Q1 2026, an estimated $538K.
Labcorp made up 0.27% of Channing Capital Management's portfolio in Q1 2026, its #61 holding.
Channing Capital Management first reported a position in Labcorp in Q3 2022 and has held it in 15 quarters since.
Channing Capital Management's Labcorp position peaked at $22.7M in Q4 2022.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Channing Capital Management's 13F filing for Q1 2026, filed 14 May 2026.